DocGo Is Maintained at Buy by Stifel

DocGo Is Maintained at Buy by Stifel

Dow JonesApr 30 19:54

Stifel Maintains Buy on DocGo, Lowers Price Target to $6.5

Stifel analyst David Grossman maintains DocGo with a Buy and lowers the price target from $8 to $6.5.

Analyst UpgradesApr 30 19:43

Analysts Offer Insights on Healthcare Companies: Regeneron (REGN), DocGo (DCGO) and Revvity (RVTY)

TipRanksApr 30 19:20

DocGo to Announce First Quarter 2024 Results on Wednesday, May 8, 2024

Management to host conference call and webcast at 5:00 p.m. ET on that day DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, announced today that the

BusinesswireApr 22 19:35

Netflix, ON Semiconductor And Other Big Stocks Moving Lower In Friday's Pre-Market Session

U.S. stock futures were lower this morning, with the Nasdaq futures declining over 100 points on Friday.Shares of Netflix, Inc. (NASDAQ:NFLX) fell sharply in today's pre-market trading following first

BenzingaApr 19 19:58

Insider Sellers Might Regret Selling DocGo Shares at a Lower Price Than Current Market Value

DocGo Inc.'s (NASDAQ:DCGO) value has fallen 13% in the last week, but insiders who sold US$3.8m worth of stock over the last year have had less success. Insiders would probably have been better off h

Simply Wall StApr 11 20:10